OQROGet OQRO Pro
Insider trade

Amneal Pharmaceuticals (AMRX)Director sold ~$277K

Deborah M. Autor, Director at Amneal Pharmaceuticals, sold ~$277K of Amneal Pharmaceuticals shares.

~$277K
Approx. value · 33K sh @ $8.34
53K
Holds after · shares reported
Traded
Nov 22, 2024
Filed
Nov 25, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 15, 2024InsiderOfficer sold ~$376K of AMRX shares in the open market
  2. Nov 21, 2024Insider · 2 peopleInsiders: 2 sales (~$172K)
  3. Nov 22, 2024 · this disclosureInsiderDirector sold ~$277K of AMRX shares in the open market

What came next

  1. Nov 22, 2024InsiderDirector sold ~$143K of AMRX shares in the open market
  2. Jan 2, 2025InsiderDirector sold ~$139K of AMRX shares in the open market
  3. Jan 8, 2025InsiderDirector sold ~$501K of AMRX shares in the open market
  4. Feb 3, 2025InsiderDirector sold ~$651K of AMRX shares in the open market
  5. Mar 3, 2025InsiderDirector sold ~$712K of AMRX shares in the open market
  6. Mar 5, 2025Insider · 4 peopleInsiders: 4 sales (~$3.1M)
  7. Mar 6, 2025InsiderOfficer sold ~$410K of AMRX shares in the open market
  8. Mar 14, 2025Insider10% owner sold ~$41.8M of AMRX shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Amneal Pharmaceuticals

For Amneal Pharmaceuticals, OQRO holds 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AMRX page.

Other recent filings by Deborah M. Autor, Director

The full history of Deborah M. Autor, Director is on the profile page.

How this filing works

Other disclosures at Amneal Pharmaceuticals

Everything OQRO holds on this company is on its AMRX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data